These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16087142)

  • 1. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
    Macchia A; Levantesi G; Franzosi MG; Geraci E; Maggioni AP; Marfisi R; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R;
    Eur J Heart Fail; 2005 Aug; 7(5):904-9. PubMed ID: 16087142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
    Verboom CN;
    Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
    Christensen JH
    Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
    Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
    Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
    Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
    Lamotte M; Annemans L; Kawalec P; Zoellners Y
    Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
    Marchioli R; Marfisi RM; Borrelli G; Chieffo C; Franzosi MG; Levantesi G; Maggioni AP; Nicolosi GL; Scarano M; Silletta MG; Schweiger C; Tavazzi L; Tognoni G
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S34-7. PubMed ID: 17876196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
    Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction].
    Aliot E
    Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():23-31. PubMed ID: 8949315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
    Marchioli R; Barzi F; Bomba E; Chieffo C; Di Gregorio D; Di Mascio R; Franzosi MG; Geraci E; Levantesi G; Maggioni AP; Mantini L; Marfisi RM; Mastrogiuseppe G; Mininni N; Nicolosi GL; Santini M; Schweiger C; Tavazzi L; Tognoni G; Tucci C; Valagussa F;
    Circulation; 2002 Apr; 105(16):1897-903. PubMed ID: 11997274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Marfisi RM; Nicolosi GL; Tavazzi L; Tognoni G; Valagussa F;
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):347-50. PubMed ID: 16645413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [N-3 polyunsaturated fatty acid in cardiovascular disease].
    Cybulska I
    Przegl Lek; 2006; 63(8):685-7. PubMed ID: 17441383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of spironolactone on mortality in patients with severe left ventricular dysfunction after acute myocardial infarction].
    Ruta J; Ptaszyński P; Maciejewski M; Chizyński K; Goch JH
    Przegl Lek; 2006; 63(12):1249-51. PubMed ID: 17642132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiarrhythmia effects of omega-3 fatty acids. A review].
    De Caterina R; Madonna R
    Ital Heart J Suppl; 2002 Mar; 3(3):297-308. PubMed ID: 12040845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term significance of Killip class and left ventricular systolic dysfunction.
    Parakh K; Thombs BD; Bhat U; Fauerbach JA; Bush DE; Ziegelstein RC
    Am J Med; 2008 Nov; 121(11):1015-8. PubMed ID: 18954850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
    Solomon SD; Zelenkofske S; McMurray JJ; Finn PV; Velazquez E; Ertl G; Harsanyi A; Rouleau JL; Maggioni A; Kober L; White H; Van de Werf F; Pieper K; Califf RM; Pfeffer MA;
    N Engl J Med; 2005 Jun; 352(25):2581-8. PubMed ID: 15972864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.
    Huikuri HV
    Europace; 2009 Dec; 11(12):1574. PubMed ID: 19933771
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heart failure and mortality: polyunsaturated fatty acids and the relevance of evidence].
    Bausano G
    Recenti Prog Med; 2011 Jan; 102(1):33-42. PubMed ID: 21516670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.